Ticker Details
Tenaya Therapeutics, Inc.
IPO Date:	June 30, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$160.58M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.26 | 4.68%
Avg Daily Range (30 D):	$0.03 | 4.62%
Avg Daily Range (90 D):	$0.04 | 4.53%

Institutional Daily Volume
Avg Daily Volume:	1.29M
Avg Daily Volume (30 D):	4.06M
Avg Daily Volume (90 D):	4.25M

Trade Size
Avg Trade Size (Sh.):	282
Avg Trade Size (Sh.) (30 D):	391
Avg Trade Size (Sh.) (90 D):	428

Institutional Trades
Total Institutional Trades:	112
Avg Institutional Trade:	$1.62M
Avg Institutional Trade (30 D):	$.64M
Avg Institutional Trade (90 D):	$1.38M
Avg Institutional Trade Volume:	.47M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.96M
Avg Closing Trade (30 D):	$.77M
Avg Closing Trade (90 D):	$1.56M
Avg Closing Volume:	706.21K

News

Mar 5, 2026 @ 6:35 PM Tenaya Therapeutics Stock Jumps After New Alnylam ... Source: Vandana Singh

Nov 8, 2025 @ 4:25 PM Tenaya Therapeutics Presents Promising Interim Cli... Source: Tenaya Therapeutics

Aug 31, 2025 @ 2:15 PM Tenaya Therapeutics Presents Interim Data from MyC... Source: Tenaya Therapeutics

Mar 4, 2025 @ 3:55 PM 2025 Market Prospects of Adeno-Associated Virus Ve... Source: Researchandmarkets.Com

Jun 27, 2024 @ 9:00 PM Tenaya Therapeutics Announces Research Leadership ... Source: Tenaya Therapeutics, Inc.

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.59	$-.11	$-.59
Diluted EPS	$-.59	$-.11	$-.59
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-90.6M	$-20.18M	$-90.6M
Operating Income / Loss	$-93.33M	$-20.78M	$-93.33M
Cost of Revenue
Net Cash Flow	$96.22M	$44.24M	$96.22M
PE Ratio